Armistice Capital, Llc's Net Worth
Armistice Capital, Llc's net worth is estimated to be at least $302,466,504.02 as of 11/23/2024. CoreStreet's estimation of Armistice Capital, Llc's net worth is based on their sale of stock and current holding of stock.
Armistice Capital, Llc is Major Shareholder at Avalo Therapeutics Inc. They have executed at least 36 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,746,138 units of AVTX stock on 06/26/2023. Their biggest sale was on 06/26/2020 when they sold 18,226,667 units of Vaxart Inc stock for $189,192,803.46. They typically trade 9 times per year.
Total value of insider buys:
- $9,968,197.05
Total value of insider sells:
- $292,498,306.97
Most recent insider trade:
- June 26, 2023
Armistice Capital, Llc's Insider Trading History
| Avalo Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 26, 2023 | Major Shareholder | 2,746,138 | $0.61 | Sell | $1,675,144.18 |
March 14, 2022 | Director | 100,000 | $0.65 | Buy | $65,000.00 |
March 10, 2022 | Director | 26,000 | $0.70 | Buy | $18,200.00 |
March 7, 2022 | Director | 325,000 | $0.66 | Buy | $214,500.00 |
March 3, 2022 | Director | 50,000 | $0.71 | Buy | $35,500.00 |
Feb. 24, 2022 | Director | 100,000 | $0.80 | Buy | $80,000.00 |
Feb. 22, 2022 | Director | 83,000 | $0.77 | Buy | $63,910.00 |
Feb. 17, 2022 | Director | 150,000 | $0.81 | Buy | $121,500.00 |
Jan. 20, 2022 | Director | 12,000 | $0.85 | Buy | $10,200.00 |
Jan. 18, 2022 | Director | 206,300 | $0.88 | Buy | $181,544.00 |
Jan. 14, 2022 | Director | 85,000 | $0.93 | Buy | $79,050.00 |
Jan. 12, 2022 | Director | 57,300 | $1.04 | Buy | $59,592.00 |
Jan. 10, 2022 | Director | 491,097 | $0.99 | Buy | $486,186.03 |
Jan. 7, 2022 | Director | 137,900 | $1.04 | Buy | $143,416.00 |
| Aytu BioScience Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 11, 2020 | Director | 1,333,334 | $6.00 | Buy | $8,000,004.00 |
| Tenax Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 8, 2020 | Director | 8,543 | $1.46 | Buy | $12,472.78 |
Sept. 4, 2020 | Director | 23,457 | $1.41 | Buy | $33,074.37 |
Sept. 2, 2020 | Director | 20,000 | $1.47 | Buy | $29,400.00 |
Aug. 31, 2020 | Director | 20,000 | $1.45 | Buy | $29,000.00 |
Aug. 27, 2020 | Director | 12,000 | $1.50 | Buy | $18,000.00 |
Aug. 24, 2020 | Major Shareholder | 5,692 | $1.47 | Buy | $8,367.24 |
Aug. 21, 2020 | Director | 116,242 | $1.44 | Buy | $167,388.48 |
Aug. 19, 2020 | Director | 70,767 | $1.45 | Buy | $102,612.15 |
| Vaxart Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 29, 2020 | Director | 9,385,386 | $8.29 | Sell | $77,804,849.94 |
June 26, 2020 | Director | 18,226,667 | $10.38 | Sell | $189,192,803.46 |
June 3, 2020 | Director | 400,000 | $2.77 | Sell | $1,108,000.00 |
June 1, 2020 | Director | 200,000 | $2.74 | Sell | $548,000.00 |
May 27, 2020 | Director | 200,000 | $2.61 | Sell | $522,000.00 |
May 18, 2020 | Director | 650,000 | $2.86 | Sell | $1,859,000.00 |
May 14, 2020 | Director | 834,669 | $3.02 | Sell | $2,520,700.38 |
May 8, 2020 | Director | 100,000 | $2.52 | Sell | $252,000.00 |
May 6, 2020 | Director | 50,000 | $2.58 | Sell | $129,000.00 |
May 4, 2020 | Director | 957,469 | $2.65 | Sell | $2,537,292.85 |
April 30, 2020 | Director | 4,434,296 | $2.96 | Sell | $13,125,516.16 |
| Cassava Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2018 | Major Shareholder | 1,200,000 | $1.02 | Sell | $1,224,000.00 |
| Alimera Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 2, 2018 | Major Shareholder | 8,000 | $1.16 | Buy | $9,280.00 |